Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Naresh Solanki

Adolescent Medicine Lake St Louis, MO Medical Doctor

NPI 1225007412 CMS profile 10403

100 Brevco Plz, Suite 101, Lake St Louis, MO 63367

Open in the dashboard

General payments

$6,458

284 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$3,581 paid to institutions, not to them · program year 2019

Through program year 2025, Naresh Solanki of Lake St Louis, MO is reported in the CMS Open Payments database as having received $6,458 across 284 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $3,581 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Adolescent Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,476 57
2024 General $1,135 44
2023 General $1,044 48
2022 General $915 46
2021 General $604 31
2020 General $399 16
2019 General $885 42

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Naresh Solanki
  • Adolescent Medicine median
  • Middle half of Adolescent Medicine
  • National median

In program year 2025, general payments to Naresh Solanki were reported at $1,476. Among 914 Adolescent Medicine profiles paid that year, the median was $100 and the middle half received between $40 and $207.

Show as a table
Year Naresh Solanki Adolescent Medicine median Middle half National median
2019 $885 $95 $36–$198 $163
2020 $399 $50 $23–$111 $114
2021 $604 $67 $27–$179 $132
2022 $915 $79 $29–$189 $149
2023 $1,044 $100 $39–$194 $160
2024 $1,135 $93 $38–$195 $164
2025 $1,476 $100 $40–$207 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $1,020 55 payments
  2. Corium, Inc. $919 35 payments
  3. Ironshore Pharmaceuticals Inc. $822 31 payments
  4. Tris Pharma Inc $707 30 payments
  5. GlaxoSmithKline, LLC. $514 15 payments
  6. Collegium Pharmaceutical, Inc. $284 10 payments
  7. kaleo, Inc. $217 15 payments
  8. Cranial Technologies, Inc $192 9 payments
  9. Sanofi Pasteur Inc. $173 8 payments
  10. Neos Therapeutics, LP $171 10 payments
  11. Other $1,439 66 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $6,458 284 payments
Products named General payments · program years 2019–2025
  1. Azstarys $919 35 payments
  2. QELBREE Psychology $662 37 payments
  3. BEXSERO $374 13 payments
  4. Qelbree Viloxazine Hydrochloride $358 18 payments
  5. JORNAY PM Central Nervous Stimulant ADHD $352 12 payments
  6. JORNAY PM Central Nervous System Stimulant $343 16 payments
  7. Dyanavel XR Adhd $298 11 payments
  8. Jornay PM Adhd $284 10 payments
  9. Dyanavel XR Adhd $232 10 payments
  10. AUVI-Q $202 14 payments
  11. Other $3,769 174 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

284 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adolescent Medicine in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record